News About: Pharm. Industry


Choong-wae develops generic drug for imipenem

Choong-wae Pharm said on June 7 that it has succeeded in developing the first generic drug of imipenem, a broad-spectrum antibiotic following penicillin and cephalosporin families. Imipenem, developed by the US dru...

SK Chemical took approval of an anti-coagulation drug.

SK Chemical and SK Pharmaceutical secured the KFDA approval of "Hootan", an anti-coagulation drug, for the treatment of blood coagulation and thrombo-embolism for patients on blood dialysis and acute pancreatitis, on ...

Boryung to set up SCM system.

Boryung Pharm. Co. announced that for the first time in the pharmaceutical industry of Korea they launched SCM (supply chain management) system in their purchase works, providing a package form of internet logistic se...

Sanofi-Synthelabo launches Cronosphere, innovative anti-epileptic drug

Sanofi-Synthelabo said it has launched Cronosphere, a novel dosage form of Depakine (sodium valproate) for the treatment of epilepsy. Cronosphere is a sustained release dosage form using a prilling method. Sphe...

815 drugs to be incentive items for substituted dispensing.

About 815 drugs could be under the category of "Incentive items for cheaper substituted dispensing" as of the end of May this year, which gives an incentive at about 30% out of the price differences of the cheap subst...

Domestic pharmaceutical industry rushes to expand global operations

Korea's pharmaceutical firms, including a major business interest group, are scurrying to expand their foreign operations in a bid to strength their presence in the global market beyond already saturated domestic phar...

Medium- and small-sized pharmaceutical firms now turn to Internet

Amid depressed consumer demand and a slumping economy, sales of domestic medium- and small-sized pharmaceutical firms involved in functional health foods and cosmetics, via Internet community and on-line shopping mall...

Preoccupation of lst generic drug registration in hot competition.

Most of leading domestic pharmaceutical companies are in severe competition for earlier registration of the copy products whose patents be terminated than the rivals in view of preoccupying the already well establishe...

Assigned bio-equivalent tests may reach 1,600 items this year.

When an entire process is assignable to the company authorized for the bio-equivalent tests, so called assigned bio-equivalent test, which recognized the equivalency even without actual tests when the bio-equivalent t...

Foreign makers battle for Korean lip protective market

Business sources say that the domestic lip protective market has emerged as an arena of competition between two foreign makers, Wyeth Korea and Nivea, as KGC Sang-A plans to discontinue its business operation of LipPl...

Most Read News


April
January
February
March
April
May
June
July
August
September
October
November
December
2025
1950
1951
1952
1953
1954
1955
1956
1957
1958
1959
1960
1961
1962
1963
1964
1965
1966
1967
1968
1969
1970
1971
1972
1973
1974
1975
1976
1977
1978
1979
1980
1981
1982
1983
1984
1985
1986
1987
1988
1989
1990
1991
1992
1993
1994
1995
1996
1997
1998
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
2032
2033
2034
2035
2036
2037
2038
2039
2040
2041
2042
2043
2044
2045
2046
2047
2048
2049
2050
SunMonTueWedThuFriSat
30
31
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
1
2
3
00:00
01:00
02:00
03:00
04:00
05:00
06:00
07:00
08:00
09:00
10:00
11:00
12:00
13:00
14:00
15:00
16:00
17:00
18:00
19:00
20:00
21:00
22:00
23:00
TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.